SRIDEVI KODALI: Open Payments
NPI 1053358630 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 14 payments from 10 companies in 2025. Trend: 2023 $1,432 · 2024 $658 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Validus Pharmaceuticals LLC | 2 | $47 |
| Janssen Biotech, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
Products named: HETLIOZ, RALDESY, FANAPT, REXULTI, CARVYKTI, COBENFY, INGREZZA, CAPLYTA.
Industry payments across MI — which companies pay providers there.
